X users have already reported using the new Bitcoin payment feature at coffee shops across the United States. Payment processor Square has launched its Bitcoin payment feature for sellers, allowing them to opt in and accept Bitcoin at checkout through its point-of-sale system. Jack Dorsey, co-founder of Block, which owns Square, said in an X post on Monday that with the new feature, merchants using Square can receive Bitcoin to Bitcoin, Bitcoin to fiat, fiat to Bitcoin or fiat to fiat payments. At the same time, Jacob Szymik, an account executive at Square, stated that Bitcoin (BTC) payments are currently only available for in-person purchases and point-of-sale terminals, but online and invoicing options are “in the works,” and teased that updates would be coming soon. Read more
BitMine’s massive ETH accumulation accelerated last week, adding 110,288 Ether to its $12.5 billion treasury as it targets 5% of the total supply. BitMine’s digital treasury accumulation is showing no signs of slowing down, with its latest week of Ether buying marking a 34% increase from the week before. BitMine Immersion Technologies announced the purchase of 110,288 Ether (ETH) on Monday, bringing its total to 3,505,723 ETH at an average purchase price of $3,639 per token. As part of the announcement, BitMine’s chairman Tom Lee said the recent ETH price dip presented an attractive opportunity” for the firm, as he went on to highlight Ether adoption happening on Wall Street: Read more
Propanc Biopharma said it will build a crypto treasury after securing up to $100 million from Hexstone Capital to further its potential cancer treatment and reignite investor interest. Australia-based Propanc Biopharma has announced it has secured up to $100 million from a crypto-focused family office to launch a crypto treasury — a move its CEO described as “transformative” as its cancer therapy product enters human trials next year. The private placement, structured through convertible preferred stock, provides Propanc with an initial $1 million investment and up to $99 million in follow-on funding over the next 12 months from Hexstone Capital, a family office that invests in several crypto treasury companies. The cancer-treating biotech company stated that the proceeds will be used to build a digital asset treasury and accelerate the development of its lead cancer therapy, PRP, which aims to enter first-in-human trials in the second half of 2026. Read more